MYO
MYOMO, INC.
+0.02 (+1.56%)1.31USD193K成交股數51.9M市值–本益比(近四季)1.2股價營收比+21.3%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 11.7M+21% | 10.1M+3% | 11.4M+23% | 10.1M+34% | 9.7M+157% | 9.8M+107% | 9.2M+81% | 7.5M+26% | 3.8M | 4.8M | 5.1M | 6.0M |
| 營業成本 | 73K | 60K | −81K | 98K | 60K | 32K | 133K | 122K | 112K | −1.4M | 33K | 266K |
| 毛利 | 8.4M+39% | 6.9M+4% | 7.8M+12% | 6.4M+21% | 6.1M+163% | 6.6M+113% | 6.9M+99% | 5.3M+24% | 2.3M | 3.1M | 3.5M | 4.3M |
| 毛利率 | 72.1% | 68.2% | 68.6% | 63.8% | 62.7% | 67.2% | 75.4% | 70.8% | 61.2% | 65.3% | 68.7% | 71.8% |
| 研發費用 | 1.7M | 1.6M | 1.6M | 1.5M | 2.0M | 1.8M | 1.2M | 1.0M | 956K | 878K | 717K | 564K |
| 銷售管理費用 | 3.7M | 3.6M | 3.4M | 3.2M | 3.4M | 3.9M | 3.3M | 2.7M | 2.9M | 4.7M | 4.8M | 4.8M |
| 營業利益 | −2.3M-51% | −3.2M-10% | −2.8M+190% | −3.5M+215% | −4.6M+18% | −3.5M+45% | −958K-53% | −1.1M+1% | −3.9M | −2.4M | −2.0M | −1.1M |
| 營業利益率 | -19.3% | -31.2% | -24.4% | -34.9% | -47.6% | -35.8% | -10.4% | -14.8% | -103.6% | -51.2% | -39.9% | -18.5% |
| 稅後淨利 | −4.0M-13% | −3.0M-13% | −3.8M+297% | −3.7M+227% | −4.6M+21% | −3.5M+44% | −966K-52% | −1.1M+11% | −3.8M | −2.4M | −2.0M | −1.0M |
| 淨利率 | -34.4% | -29.8% | -33.8% | -36.3% | -48.0% | -35.2% | -10.5% | -14.9% | -102.2% | -50.7% | -39.9% | -17.0% |
| 稀釋 EPS | -0.09-18% | -0.07-12% | -0.09+200% | -0.09+200% | -0.11+10% | -0.08+14% | -0.03-50% | -0.03-25% | -0.10 | -0.07 | -0.06 | -0.04 |
| 稀釋股數 | 42.7M | 42.3M | 41.9M | 42.2M | 41.6M | 41.5M | 38.0M | 37.4M | 36.8M | 29.5M | 35.3M | 28.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.2M | 11.4M | 14.1M | 12.6M | 14.2M | 19.8M | 6.6M | 5.8M | 5.4M | 6.9M | 6.9M | 6.0M |
| 應收帳款 | 4.9M | 4.8M | 4.1M | 5.3M | 7.1M | 4.7M | 3.7M | 2.5M | 1.7M | 2.4M | 2.5M | 1.6M |
| 存貨 | 3.2M | 3.5M | 3.1M | 3.6M | 4.1M | 3.4M | 3.4M | 2.6M | 2.4M | 1.8M | 1.5M | 1.3M |
| 總資產 | 35.3M | 36.8M | 38.6M | 34.1M | 38.7M | 40.9M | 16.3M | 16.2M | 16.5M | 14.6M | 17.1M | 13.3M |
| 有息負債 | 11.5M | 10.9M | 11.2M | 2.4M | 1.3M | – | – | – | – | – | – | – |
| 總負債 | 29.5M | 27.8M | 27.2M | 19.5M | 21.1M | 19.2M | 7.0M | 6.5M | 5.6M | 5.6M | 6.0M | 4.5M |
| 股東權益 | 5.8M | 9.0M | 11.4M | 14.6M | 17.6M | 21.7M | 9.3M | 9.7M | 10.9M | 9.0M | 11.0M | 8.8M |
| 負債比 | 83.5% | 75.5% | 70.5% | 57.1% | 54.5% | 46.9% | 43.0% | 40.2% | 34.0% | 38.4% | 35.4% | 33.7% |
| 淨現金(現金 − 有息負債) | −313K | 470K | 2.9M | 10.1M | 12.9M | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.2M-18% | – | – | – | −2.7M | – | – | −3.2M | – | – | – |
| 資本支出 | – | 328K | – | – | – | 671K | – | – | 60K | – | – | – |
| 自由現金流 | – | −2.5M-25% | – | – | – | −3.3M | – | – | −3.3M | – | – | – |
| 折舊攤銷 | – | 292K | – | – | – | 158K | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -25.0% | – | – | – | -34.0% | – | – | -88.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
主要客戶2025 年度 · 40.9M
| Direct To Patient | 30.4M | 74.3% | +20.1% |
|---|---|---|---|
| Clinical And Medical Providers | 10.5M | 25.7% | +45.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 40.9M | +25.7% | −15.6M | -38.1% | -0.37 | −16.3M |
| FY2024 | 32.6M | +69.2% | −6.2M | -19.0% | -0.16 | −4.7M |
| FY2023 | 19.2M | +23.7% | −8.1M | -42.1% | -0.28 | −6.3M |
| FY2022 | 15.6M | +12.3% | −10.7M | -68.9% | -1.52 | −10.3M |
| FY2021 | 13.9M | +82.7% | −10.4M | -74.9% | -1.89 | −9.9M |
| FY2020 | 7.6M | +97.6% | −11.6M | -152.5% | -3.67 | −9.1M |
| FY2019 | 3.8M | +57.0% | −10.7M | -279.1% | -20.79 | −10.4M |
| FY2018 | 2.4M | – | −10.3M | -422.1% | -25.18 | −9.7M |